Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Farmers Insurance
McKinsey
US Department of Justice
Moodys
McKesson
Federal Trade Commission
Harvard Business School

Generated: June 23, 2018

DrugPatentWatch Database Preview

AMPHETAMINE SULFATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Amphetamine Sulfate patents expire, and what generic alternatives are available?

Amphetamine Sulfate is a drug marketed by Lannett and is included in one NDA.

The generic ingredient in AMPHETAMINE SULFATE is amphetamine sulfate. There are fifty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amphetamine sulfate profile page.
Summary for AMPHETAMINE SULFATE
Drug patent expirations by year for AMPHETAMINE SULFATE

US Patents and Regulatory Information for AMPHETAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 083901-001 Aug 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 083901-002 Aug 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
US Army
AstraZeneca
Federal Trade Commission
Cantor Fitzgerald
Colorcon
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.